Mae Sheikh‐Ali

774 total citations
25 papers, 475 citations indexed

About

Mae Sheikh‐Ali is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Mae Sheikh‐Ali has authored 25 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Mae Sheikh‐Ali's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (6 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Mae Sheikh‐Ali is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (6 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Mae Sheikh‐Ali collaborates with scholars based in United States, Denmark and Canada. Mae Sheikh‐Ali's co-authors include Arshag D. Mooradian, Michael J. Haas, Joe M. Chehade, Senan Sultan, Yogish C. Kudva, Jia Xu, W. Schwenk, John J. Miles, Brad S. Karon and Ananda Basu and has published in prestigious journals such as Diabetes Care, Free Radical Biology and Medicine and CHEST Journal.

In The Last Decade

Mae Sheikh‐Ali

24 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mae Sheikh‐Ali United States 12 179 115 99 98 96 25 475
G. De Mattia Italy 11 216 1.2× 199 1.7× 109 1.1× 67 0.7× 117 1.2× 21 627
Luuk te Riet Netherlands 9 234 1.3× 99 0.9× 96 1.0× 78 0.8× 280 2.9× 10 855
Hirotaka Tsubouchi Japan 8 208 1.2× 269 2.3× 162 1.6× 53 0.5× 232 2.4× 9 827
Chie Ohmura Japan 13 211 1.2× 70 0.6× 86 0.9× 21 0.2× 105 1.1× 25 461
Yeshao Wen United States 11 134 0.7× 176 1.5× 88 0.9× 83 0.8× 296 3.1× 12 748
Anu Shah United States 8 75 0.4× 83 0.7× 66 0.7× 27 0.3× 268 2.8× 12 486
Hanaa Z. Yassin Egypt 10 91 0.5× 100 0.9× 45 0.5× 29 0.3× 112 1.2× 10 412
Yusuf Olğar Türkiye 15 157 0.9× 116 1.0× 117 1.2× 24 0.2× 354 3.7× 41 717
Maria Apostolopoulou Germany 11 173 1.0× 167 1.5× 148 1.5× 49 0.5× 252 2.6× 17 615
M. Cassone‐Faldetta Italy 8 123 0.7× 130 1.1× 52 0.5× 22 0.2× 90 0.9× 10 436

Countries citing papers authored by Mae Sheikh‐Ali

Since Specialization
Citations

This map shows the geographic impact of Mae Sheikh‐Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mae Sheikh‐Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mae Sheikh‐Ali more than expected).

Fields of papers citing papers by Mae Sheikh‐Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mae Sheikh‐Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mae Sheikh‐Ali. The network helps show where Mae Sheikh‐Ali may publish in the future.

Co-authorship network of co-authors of Mae Sheikh‐Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Mae Sheikh‐Ali. A scholar is included among the top collaborators of Mae Sheikh‐Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mae Sheikh‐Ali. Mae Sheikh‐Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheikh‐Ali, Mae, et al.. (2024). Insulin icodec: A novel once‐weekly treatment for diabetes. Diabetic Medicine. 41(10). e15414–e15414.
2.
Ashchi, Majdi, Mohannad Bisharat, Ashwini Gore, et al.. (2023). A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction. American Journal of Cardiovascular Drugs. 23(4). 393–406. 5 indexed citations
3.
Gore, Ashwini, et al.. (2022). Imeglimin in type 2 diabetes. Drugs of today. 58(9). 437–449. 2 indexed citations
4.
Hardy, Jennifer, Rebecca F. Goldfaden, Jessica Reid, et al.. (2021). A Review on the Efficacy and Safety of Oral Semaglutide. Drugs in R&D. 21(2). 133–148. 19 indexed citations
5.
Reid, Jessica, et al.. (2020). Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention. American Journal of Cardiovascular Drugs. 20(5). 419–429. 2 indexed citations
6.
Reid, Jessica, et al.. (2020). A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia. American Journal of Cardiovascular Drugs. 20(6). 535–548. 23 indexed citations
7.
Reid, Jessica, et al.. (2019). <p>A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1897–1911. 7 indexed citations
8.
Reid, Jessica, et al.. (2019). Efpeglenatide. Glucagon-like peptide 1 (GLP-1) receptor agonist, Treatment for type 2 diabetes. Drugs of the Future. 44(6). 435–435. 3 indexed citations
10.
Sheikh‐Ali, Mae, et al.. (2014). 25-Hydroxyvitamin D Levels and Acute Cellular Rejection in Liver Transplant Patients. Endocrine Practice. 20(8). 769–774. 2 indexed citations
11.
Sheikh‐Ali, Mae, Prafull Raheja, & Nancy Borja‐Hart. (2013). Medical Management and Strategies to Prevent Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus. Postgraduate Medicine. 125(1). 17–33. 13 indexed citations
12.
Sheikh‐Ali, Mae, et al.. (2012). Role of Vitamin D in the Onset, Progression, and Severity of Multiple Sclerosis. Endocrine Practice. 19(1). 129–136. 15 indexed citations
13.
14.
Haas, Michael J., et al.. (2012). Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells. Free Radical Biology and Medicine. 52(11-12). 2161–2167. 31 indexed citations
15.
Chehade, Joe M., et al.. (2010). The effect of healthcare provider education on diabetes management of hospitalised patients. International Journal of Clinical Practice. 64(7). 917–924. 5 indexed citations
16.
Sheikh‐Ali, Mae, Joe M. Chehade, & Arshag D. Mooradian. (2010). The Antioxidant Paradox in Diabetes Mellitus. American Journal of Therapeutics. 18(3). 266–278. 51 indexed citations
17.
Sheikh‐Ali, Mae, et al.. (2010). Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition. 26(11-12). 1146–1150. 62 indexed citations
18.
Sheikh‐Ali, Mae, et al.. (2009). Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells. Diabetes Research and Clinical Practice. 87(2). 161–166. 40 indexed citations
19.
Sheikh‐Ali, Mae, Brad S. Karon, Ananda Basu, et al.. (2008). Can Serum β-Hydroxybutyrate Be Used to Diagnose Diabetic Ketoacidosis?. Diabetes Care. 31(4). 643–647. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026